Board of Directors

The SITC Board of Directors have full responsibility for the management, direction and control of the business, policies and affairs of the society, subject only to limitations set forth in the society's Articles of Incorporation and Bylaws.

Officer Directors

Dr-Butterfield_IM_Final.jpg

Lisa H. Butterfield, PhD (2016-2018)

President
University of Pittsburgh

Sznol__Mario_2016.jpg

Mario Sznol, MD (2016-2018)

Vice President
Yale School of Medicine

Hodi__Stephen_2016.jpg

F. Stephen Hodi, Jr., MD (2014-2017)

Secretary/Treasurer
Dana-Farber Cancer Institute

Kaufman.jpg

Howard L. Kaufman, MD, FACS (2016-2018)

(ex-officio)
Immediate Past President
Rutgers Cancer Institute of New Jersey

 

At-Large Directors

Demaria__Sandra_2015.jpg

Sandra Demaria, MD (2013-2017)

New York University School of Medicine

Drake__Chuck.jpg

Charles G. Drake, MD, PhD (2016-2019)

Columbia University Medical Center

Emens__Leisha_2015.png

Leisha A. Emens, MD, PhD (2016-2019)

Johns Hopkins University

Ferris__Robert__cropped_.png

Robert L. Ferris, MD, PhD, FACS (2014-2017)

University of Pittsburgh Cancer Institute

Galon__Jerome.png

Jérôme Galon, PhD (2015-2018)

 French National Institute of Health and Medical Research, Cordeliers Research Center

Hege__Kristen.jpg

Kristen Hege, MD (2016-2019)

Celgene Corporation

Khleif__Samir_photo.png

Samir N. Khleif, MD (2015-2018)

Georgia Regents University Cancer Center

Ohashi_Pamela.png

Pamela S. Ohashi, PhD (2015-2018)

Princess Margaret Cancer Centre, University Health Network

Overwijk__Willem.jpg

Willem W. Overwijk, PhD (2014-2017)

University of Texas, MD Anderson Cancer Center

 

Ex-Officio

Romero%20Photo.jpg

Pedro J. Romero, MD

University of Lausanne
Editor-in-Chief
Journal for ImmunoTherapy of Cancer